Nielsen UB - Search Results

1

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC. Park JW, et al. Among authors: nielsen ub. J Control Release. 2001 Jul 6;74(1-3):95-113. doi: 10.1016/s0168-3659(01)00315-7. J Control Release. 2001. PMID: 11489487

2

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC. Park JW, et al. Among authors: nielsen ub. Clin Cancer Res. 2002 Apr;8(4):1172-81. Clin Cancer Res. 2002. PMID: 11948130

3

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.

Nielsen UB, Kirpotin DB, Pickering EM, Hong K, Park JW, Refaat Shalaby M, Shao Y, Benz CC, Marks JD. Nielsen UB, et al. Biochim Biophys Acta. 2002 Aug 19;1591(1-3):109-118. doi: 10.1016/s0167-4889(02)00256-2. Biochim Biophys Acta. 2002. PMID: 12183061 Free article.

4

Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Kirpotin DB, et al. Among authors: nielsen ub. Cancer Res. 2006 Jul 1;66(13):6732-40. doi: 10.1158/0008-5472.CAN-05-4199. Cancer Res. 2006. PMID: 16818648

5

Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.

Nielsen UB, Adams GP, Weiner LM, Marks JD. Nielsen UB, et al. Cancer Res. 2000 Nov 15;60(22):6434-40. Cancer Res. 2000. PMID: 11103810

6

Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function.

Neve RM, Nielsen UB, Kirpotin DB, Poul MA, Marks JD, Benz CC. Neve RM, et al. Among authors: nielsen ub. Biochem Biophys Res Commun. 2001 Jan 12;280(1):274-9. doi: 10.1006/bbrc.2000.4104. Biochem Biophys Res Commun. 2001. PMID: 11162510

7

A novel assay for monitoring internalization of nanocarrier coupled antibodies.

Nielsen UB, Kirpotin DB, Pickering EM, Drummond DC, Marks JD. Nielsen UB, et al. BMC Immunol. 2006 Oct 2;7:24. doi: 10.1186/1471-2172-7-24. BMC Immunol. 2006. PMID: 17014727 Free PMC article.

8

Selection of tumor-specific internalizing human antibodies from phage libraries.

Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD. Poul MA, et al. Among authors: nielsen ub. J Mol Biol. 2000 Sep 1;301(5):1149-61. doi: 10.1006/jmbi.2000.4026. J Mol Biol. 2000. PMID: 10966812

9

Building and characterizing antibody-targeted lipidic nanotherapeutics.

Kirpotin DB, Noble CO, Hayes ME, Huang Z, Kornaga T, Zhou Y, Nielsen UB, Marks JD, Drummond DC. Kirpotin DB, et al. Among authors: nielsen ub. Methods Enzymol. 2012;502:139-66. doi: 10.1016/B978-0-12-416039-2.00007-0. Methods Enzymol. 2012. PMID: 22208985

10

Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.

Zhou Y, Goenaga AL, Harms BD, Zou H, Lou J, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD. Zhou Y, et al. Among authors: nielsen ub. Mol Cancer Ther. 2012 Jul;11(7):1467-76. doi: 10.1158/1535-7163.MCT-11-1038. Epub 2012 May 7. Mol Cancer Ther. 2012. PMID: 22564724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page